EyePoint Pharmaceuticals is a pharmaceutical company that develops and commercializes ophthalmic products to treat eye diseases in the US, China, and the UK. Their products include ILUVIEN, YUTIQ, DEXYCU, EYP-1901, and YUTIQ50, with strategic collaborations with companies such as Alimera Sciences, Bausch & Lomb, and OncoSil Medical UK Limited. EyePoint Pharmaceuticals was formerly known as pSivida Corp and was established in 1987, with headquarters in Watertown, Massachusetts.